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Purpose/Objective: By eliminating user variability, 
automated planning aims to reduce treatment planning time 
and improve plan quality. We investigated the use of 
automated planning for stereotactic body radiation therapy 
(SBRT) in lung cancer patients. 
Materials and Methods: Ten patients with peripherally 
located T1N0M0 lung cancer were planned to receive a total 
dose of 60 Gy in 3 fractions to at least 95% of the planning 
target volume (PTV). Delineation of target volumes and 
organs at risk (OARs) was performed manually in Pinnacle 9.2 
(Philips Medical Systems Inc, USA). Intensity modulated 
radiation therapy (IMRT) treatment plan optimization was 
performed using our in-house treatment planning system 
developed from Gratis (Sherouse Systems Inc, USA). We 
recorded the time necessary for optimization including the 
generation of beams and initial segments, segment weight 
and shape optimization, and final dose calculation. Nine non-
coplanar beams and a standard set of optimization objectives 
were used. The resulting plans are further referred to as 
manual plans (MPs). Using an evaluation version of the 
Pinnacle 9.10 Auto-Planning software an additional 
automated plan (AP) was created for each patient. The same 
beam directions were used as for the MP. Based on the 
clinical goals for the PTV (in terms of prescribed dose) and 
OARs, the Auto-Planning software automatically creates 
derived structures, optimization objectives and constraints, 
and performs IMRT optimization. As for the MP, we recorded 
the AP optimization time including final dose calculation.  
Both sets of treatment plans were blindly evaluated by three 
experienced radiation oncologists (ROs). A scorecard was 
used incorporating the clinical goals in terms of dose-volume 
constraints for the PTV (D95, D99 and D02, in which xx% of the 
PTV volume receives a dose of at least Dxx), lungs (Dmean, V05 
and V20, in which Vxx is the volume receiving at least xx Gy), 
spinal cord and esophagus planning risk volumes, plexus 
brachialis, heart, aorta, trachea, main stem bronchus and 
chest wall (D02). Based on the scorecards, the full 3D dose 
distribution and dose-volume histograms, the ROs judged the 
clinical acceptability of each MP and AP separately, and if 
both were acceptable, they indicated their preference. 
Results: The average optimization time amounted to 28’06' 
(1 SD = 4’39') for the MPs and 6’23' (1 SD = 0’27') for the APs. 
The optimization time was significantly shorter for the APs 
than for the MPs (paired t-test, p < 0.001). All 20 treatment 
plans were judged to be clinically acceptable by all three 
ROs. Two ROs preferred the AP over the MP for 10/10 
patients, while the third RO preferred the AP over the MP for 
6/10 patients. 
Conclusions: Automated planning significantly reduced 
treatment plan optimization time for lung SBRT, without 
compromising plan quality.  
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Purpose/Objective: We investigated whether the automated 
planning module in the beta version of Pinnacle3 9.10.60013 
(Philips Healthcare, Fitchburg, WI, USA) is able to create 
treatment plans with consistent quality, independent of the 
experience of the planner. 
Materials and Methods: We tested the auto-planning module 
for several treatment sites and compared the results with the 
applied original clinical plans. In the automated planning 
module a treatment technique template can be created for 
each tumour site and protocol. We used the same set of 
objectives as used for clinical treatment planning. Once the 
template is selected, automated planning can be activated. 
We report the comparison results for Hodgkin lymphoma 
(IMRT step-and-shoot), prostate (VMAT), breast (mix of IMRT 
(20%) and conventional (80%)) and SBRT lung plans (VMAT). 
Results: Figure 1 shows the comparison between clinical and 
automated treatment plans. The dose volume histograms and 
dose distributions are very similar. All automated plans 
fulfilled the clinical dose criteria for planning target volume 
coverage and organs at risk. 
 
 
 
 
 
Conclusions: With the automated planning module it is 
possible to consistently create high quality clinical plans for 
different tumour sites independent of the user, similar to the 
original clinical plans that were used as a reference. We 
found that the auto-planning module is intuitive for 
operators. Selecting the technique template and running 
auto-planning can be seen as the last step directly following 
contouring needed to create a real treatment planning class 
solution. Therefore, we consider auto-planning to be an 
efficient tool to produce high quality treatment plans also in 
clinical practice. 
   
 
